Search
Displaying Results For:
Mar 23, 2026
New Lyme Disease Vaccine: What We Know
A new Lyme disease vaccine could help prevent not just infection, but some of the longer-term health effects that can follow. In a large Phase 3 clinical trial, the vaccine developed by Pfizer and Valneva reduced Lyme disease cases by more than 70% in people ages 5 and older. The vaccine, known as VLA15 (PF-07307405), […]
- Clinical Trials
- Research Studies
Mar 18, 2026
ACIP Meeting Status Unclear Following Federal Court Decision
Both the official Federal Register notice and the CDC’s ACIP meetings page state that the meeting is open to the public via live webcast. However, the CDC-hosted YouTube stream remained in a “waiting” state well beyond the scheduled start time of 8:00 AM EST, with no visible indication that the meeting had begun or that an alternative […]
- Policy & Health Decisions
Mar 18, 2026
Human-Based Models May Transform Autoimmune Research
Autoimmune diseases are notoriously difficult to model in animals, as they involve complex, human-specific immune interactions. As a result, many therapies that appear promising in animal studies fail in human trials. The National Institutes of Health (NIH) has announced a $150 million investment in new research approaches designed to better replicate human biology and reduce reliance on animal […]
- Clinical Trials
- Policy & Health Decisions
- Research Studies
- Risk Factors
- Therapies
Mar 16, 2026
Hormones and MS: Pregnancy, Periods, Menopause
New insights from experts at the University of Colorado Anschutz Medical Campus highlight how hormonal changes across a woman’s life, from menstruation to pregnancy and menopause, can influence disease activity in multiple sclerosis (MS), while also emphasizing that modern treatment strategies are improving outcomes. MS is diagnosed up to three times more often in women, particularly during their reproductive […]
- Multiple Sclerosis
- Research Studies
- Risk Factors
Mar 10, 2026
How Food Proteins Help Train Immune Tolerance
Scientists have long known that the immune system learns to tolerate harmless substances (such as food) through specialized immune cells called regulatory T cells (Tregs). However, the specific dietary molecules that help train this tolerance have remained largely unknown. A study published in Science Immunology identified several food-derived proteins that appear to play a key role in this […]
- Microbiome
- Research Studies
- Risk Factors
Mar 06, 2026
Tracking T Cells Could Help Decode Autoimmune Disease
Researchers have developed a new method that allows scientists to track recently activated T cells across different organs, revealing how the body organizes immune responses during infection. The system, called TRACK (Tracking Recently Activated Cell Kinetics), uses a fluorescent marker to permanently label T cells shortly after they encounter a pathogen, allowing researchers to follow […]
- Multiple Sclerosis
- Research Studies
- Risk Factors
Mar 03, 2026
NIH Grant Funds Study of Protein That May Drive Lupus
A new $1.7 million National Institutes of Health (NIH) grant will support research into a protein that may help explain why systemic lupus erythematosus (SLE) develops and how it might be treated more precisely. The project, led by Carol Webb, Ph.D., at the University of Oklahoma College of Medicine, focuses on a protein called ARID3a, which appears in higher numbers in […]
- Lupus
- Research Studies
Mar 02, 2026
Rare Disease Day 2026 at NIH
Rare Disease Day 2026 highlighted CAR T therapy, innovative trial design, and gene editing advances with implications for autoimmune disease.
- Clinical Trials
- Events
- Research Studies
- Risk Factors
- Therapies